MedPath

CENTRICITY VISION, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Study of Endothelial Cell Condition After Cataract Surgery Performed Using Capsulorhexis or ZEPTO

Conditions
Endothelial Cell Density Loss
Interventions
Diagnostic Test: Imaging
First Posted Date
2021-05-11
Last Posted Date
2022-03-22
Lead Sponsor
Centricity Vision, Inc.
Target Recruit Count
80
Registration Number
NCT04882189
Locations
🇺🇸

UltraVision, San Antonio, Texas, United States

🇺🇸

Houston Eye Associates, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath